Literature DB >> 22696217

Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

Gill Holdsworth1, Patrick Slocombe, Carl Doyle, Bernadette Sweeney, Vaclav Veverka, Kelly Le Riche, Richard J Franklin, Joanne Compson, Daniel Brookings, James Turner, Jeffery Kennedy, Rachael Garlish, Jiye Shi, Laura Newnham, David McMillan, Mariusz Muzylak, Mark D Carr, Alistair J Henry, Thomas Ceska, Martyn K Robinson.   

Abstract

LRP5 and LRP6 are proteins predicted to contain four six-bladed β-propeller domains and both bind the bone-specific Wnt signaling antagonist sclerostin. Here, we report the crystal structure of the amino-terminal region of LRP6 and using NMR show that the ability of sclerostin to bind to this molecule is mediated by the central core of sclerostin and does not involve the amino- and carboxyl-terminal flexible arm regions. We show that this structured core region interacts with LRP5 and LRP6 via an NXI motif (found in the sequence PNAIG) within a flexible loop region (loop 2) within the central core region. This sequence is related closely to a previously identified motif in laminin that mediates its interaction with the β-propeller domain of nidogen. However, the NXI motif is not involved in the interaction of sclerostin with LRP4 (another β-propeller containing protein in the LRP family). A peptide derived from the loop 2 region of sclerostin blocked the interaction of sclerostin with LRP5/6 and also inhibited Wnt1 but not Wnt3A or Wnt9B signaling. This suggests that these Wnts interact with LRP6 in different ways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696217      PMCID: PMC3410989          DOI: 10.1074/jbc.M112.350108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.

Authors:  G Pannone; P Bufo; A Santoro; R Franco; G Aquino; F Longo; G Botti; R Serpico; B Cafarelli; A Abbruzzese; M Caraglia; S Papagerakis; L Lo Muzio
Journal:  Oncol Rep       Date:  2010-10       Impact factor: 3.906

2.  Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.

Authors:  Wenyan Lu; Chia-Chen Liu; Jaideep V Thottassery; Guojun Bu; Yonghe Li
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

Review 3.  Sclerostin: a gem from the genome leads to bone-building antibodies.

Authors:  Chris Paszty; Charles H Turner; Martyn K Robinson
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

4.  Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors.

Authors:  Luca Grumolato; Guizhong Liu; Phyllus Mong; Raksha Mudbhary; Romi Biswas; Randy Arroyave; Sapna Vijayakumar; Aris N Economides; Stuart A Aaronson
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

5.  Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

Authors:  Noriyuki Ouchi; Akiko Higuchi; Koji Ohashi; Yuichi Oshima; Noyan Gokce; Rei Shibata; Yuichi Akasaki; Akihiko Shimono; Kenneth Walsh
Journal:  Science       Date:  2010-06-17       Impact factor: 47.728

6.  Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.

Authors:  Carola Krause; Olexandr Korchynskyi; Karien de Rooij; Stella E Weidauer; David J J de Gorter; Rutger L van Bezooijen; Sarah Hatsell; Aris N Economides; Thomas D Mueller; Clemens W G M Löwik; Peter ten Dijke
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

7.  Two structural and functional domains of MESD required for proper folding and trafficking of LRP5/6.

Authors:  Jianglei Chen; Chia-Chen Liu; Qianqian Li; Christian Nowak; Guojun Bu; Jianjun Wang
Journal:  Structure       Date:  2011-03-09       Impact factor: 5.006

8.  Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.

Authors:  Maria Cristina Rosi; Ilaria Luccarini; Cristina Grossi; Anna Fiorentini; Maria Grazia Spillantini; Antonella Prisco; Carla Scali; Marco Gianfriddo; Andrea Caricasole; Georg C Terstappen; Fiorella Casamenti
Journal:  J Neurochem       Date:  2009-12-29       Impact factor: 5.372

9.  Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.

Authors:  Eric Bourhis; Christine Tam; Yvonne Franke; J Fernando Bazan; James Ernst; Jiyoung Hwang; Mike Costa; Andrea G Cochran; Rami N Hannoush
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

10.  Sclerostin binds and regulates the activity of cysteine-rich protein 61.

Authors:  Theodore A Craig; Resham Bhattacharya; Debabrata Mukhopadhyay; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2009-12-31       Impact factor: 3.575

View more
  38 in total

1.  New horizons for lipoprotein receptors: communication by β-propellers.

Authors:  Olav M Andersen; Robert Dagil; Birthe B Kragelund
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

Review 2.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

3.  Crystallization and preliminary X-ray crystallographic analysis of the sclerostin-neutralizing Fab AbD09097.

Authors:  Verena Boschert; Eva Maria Muth; Achim Knappik; Christian Frisch; Thomas D Mueller
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

Review 4.  Modulating the wnt signaling pathway with small molecules.

Authors:  Freddi Huan Tran; Jie J Zheng
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

Review 5.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

6.  Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.

Authors:  Ming-Kang Chang; Ina Kramer; Thomas Huber; Bernd Kinzel; Sabine Guth-Gundel; Olivier Leupin; Michaela Kneissel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 7.  Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Curr Opin Pharmacol       Date:  2015-04-05       Impact factor: 5.547

8.  Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.

Authors:  Philip W Addis; Catherine J Hall; Shaun Bruton; Vaclav Veverka; Ian C Wilkinson; Frederick W Muskett; Philip S Renshaw; Christine E Prosser; Bruce Carrington; Alastair D G Lawson; Robert Griffin; Richard J Taylor; Lorna C Waters; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

Review 9.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

Review 10.  LRP5 and LRP6 in development and disease.

Authors:  Danese M Joiner; Jiyuan Ke; Zhendong Zhong; H Eric Xu; Bart O Williams
Journal:  Trends Endocrinol Metab       Date:  2013-01       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.